Učitavanje...
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
BACKGROUND: A variety of immune-modulating drugs are becoming increasingly used for various cancers. Despite increasing indications and improved efficacy, they are often associated with a wide variety of immune mediated adverse events including colitis that may be refractory to conventional therapy....
Spremljeno u:
| Izdano u: | World J Gastrointest Pharmacol Ther |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6347649/ https://ncbi.nlm.nih.gov/pubmed/30697447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v10.i1.29 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|